Renasant Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,459
| Closed | -$309K | – | 174 |
|
|
2023
Q3 | $309K | Sell |
4,459
-366
| -8% | -$25.4K | 0.26% | 117 |
|
|
2023
Q2 | $455K | Sell |
4,825
-693
| -13% | -$65.4K | 0.37% | 85 |
|
|
2023
Q1 | $457K | Sell |
5,518
-1,032
| -16% | -$85.4K | 0.35% | 94 |
|
|
2022
Q4 | $489K | Buy |
6,550
+1,147
| +21% | +$85.6K | 0.37% | 94 |
|
|
2022
Q3 | $446K | Buy |
5,403
+738
| +16% | +$60.9K | 0.39% | 92 |
|
|
2022
Q2 | $444K | Sell |
4,665
-28
| -0.6% | -$2.67K | 0.36% | 91 |
|
|
2022
Q1 | $553K | Buy |
4,693
+35
| +0.8% | +$4.12K | 0.37% | 85 |
|
|
2021
Q4 | $604K | Sell |
4,658
-11
| -0.2% | -$1.43K | 0.41% | 73 |
|
|
2021
Q3 | $528K | Hold |
4,669
| – | – | 0.42% | 77 |
|
|
2021
Q2 | $484K | Sell |
4,669
-172
| -4% | -$17.8K | 0.37% | 87 |
|
|
2021
Q1 | $405K | Sell |
4,841
-116
| -2% | -$9.71K | 0.33% | 101 |
|
|
2020
Q4 | $452K | Buy |
+4,957
| New | +$452K | 0.37% | 86 |
|